Institutional Fund
Pfizer Inc
New York, NYCIK 780035 filings on record
Portfolio Value
$238.78M
Q1 2026
Holdings
18
Reported positions
New Buys
1
Opened this quarter
QoQ Change
+1.0%
from $236.46M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Oric Pharmaceuticals Inc24.1%
- Allogene Therapeutics Inc20.9%
- Arvinas Inc14.6%
- Celcuity Inc13.1%
- Zura Bio Ltd7.1%
- Wave Life Sciences Ltd5.0%
- Other15.2%
Portfolio Holdings
18 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Oric Pharmaceuticals Inc | 4.78M | $57.65M | 24.1% | −595.9K | Reduced |
| 2 | Allogene Therapeutics Inc | 22.03M | $49.79M | 20.9% | 0 | Held |
| 3 | Arvinas Inc | 3.46M | $34.92M | 14.6% | 0 | Held |
| 4 | Celcuity Inc | 295.7K | $31.35M | 13.1% | −53.8K | Reduced |
| 5 | Zura Bio Ltd | 2.84M | $16.83M | 7.1% | −131.1K | Reduced |
| 6 | Wave Life Sciences Ltd | 1.88M | $11.93M | 5.0% | 0 | Held |
| 7 | Pyxis Oncology Inc | 7.03M | $9.21M | 3.9% | 0 | Held |
| 8 | Caribou Biosciences Inc | 4.69M | $8.35M | 3.5% | 0 | Held |
| 9 | Spero Therapeutics Inc | 2.36M | $5.50M | 2.3% | 0 | Held |
| 10 | Biohaven Ltd | 505.6K | $4.23M | 1.8% | 0 | Held |
8 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio